Journal of Urologic Oncology

JUO, the Journal of Urologic Oncology, Celebrates Its Second Anniversary: Cheol Kwak; Journal of Urologic Oncology. 2024;22(1):1-3. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.24edi001; Full text PubReader ePub PDF

Prostate Cancer

Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review: Chang Wook Jeong; Journal of Urologic Oncology. 2024;22(1):4-10. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600220011
Cited By 3; Full text PubReader ePub PDF

Multidisciplinary Team Approach in Prostate-Specific Membrane Antigen Theranostics for Prostate Cancer: A Narrative Review: Minseok Suh, Gi Jeong Cheon; Journal of Urologic Oncology. 2024;22(1):11-20. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600200010
Cited By 1; Full text PubReader ePub PDF

High-Grade Late Urinary Toxicity Following Salvage Radiotherapy After Radical Prostatectomy: A Retrospective Cohort Study: Seung-Kwon Choi, Myong Kim, Sang Mi Lee, Cheryn Song, Jun Hyuk Hong, Choung-Soo Kim, Hanjong Ahn; Journal of Urologic Oncology. 2024;22(1):21-28. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600080004
Cited By 1; Full text PubReader ePub PDF

Enzalutamide Maintenance Following Docetaxel in Metastatic Castration-Naive Prostate Cancer: A Pilot Feasibility Study: Sung Hee Lim, Sung Wook Cho, Jae Hoon Chung, Wan Song, Minyong Kang, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Se Hoon Park; Journal of Urologic Oncology. 2024;22(1):29-33. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600040002
Cited By 1; Full text PubReader ePub PDF

Kidney Cancer

Targeted Therapy Following Metastasectomy for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysis: Hui Mo Gu, Seung Il Jung, Dongdeuk Kwon, Myung Ha Kim, Jae Hung Jung, Mi Ah Han, Seung Hwan Lee, In Gab Jeong, Sun Il Kim, Eu Chang Hwang; Journal of Urologic Oncology. 2024;22(1):34-41. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600140007
Cited By 2; Full text PubReader ePub PDF Supplementary Material

Global Renal Cell Carcinoma Research Trends Over 30 Years: A PRISMA-Compliant Bibliometric Analysis: Jung Hoon Kim, Ji Woong Hwang; Journal of Urologic Oncology. 2024;22(1):42-51. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600120006
Cited By 3; Full text PubReader ePub PDF

Prognostic Factors and Cancer-Specific Survival of Surgically Managed Renal Cell Carcinoma With Venous Thrombus: A 30-Year Experience at a Tertiary Referral Center: Hyun Young Lee, Yunjoong Kim, Bumjin Lim, Dalsan You, Cheryn Song, In Gab Jeong, Bumsik Hong, Jun Hyuk Hong, Hanjong Ahn, Jungyo Suh; Journal of Urologic Oncology. 2024;22(1):52-58. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.234600600030
Cited By 1; Full text PubReader ePub PDF

Clinical Characteristics and Outcomes of TFE3-Rearranged/TFEB-Altered Renal Cell Carcinoma with Systemic Therapies, Including Tyrosine Kinase Inhibitors or Immune Checkpoint Inhibitors: An Observational Study: Joohyun Hong, Ghee Young Kwon, Minyong Kang, Seong Il Seo, Se Hoon Park; Journal of Urologic Oncology. 2024;22(1):59-67. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.234600660033
Cited By 1; Full text PubReader ePub PDF

Bladder Cancer

Nephron-Sparing Surgery for Upper Urinary Tract Urothelial Carcinoma: Sung Han Kim, Ilma S. Savul, Seth P. Lerner; Journal of Urologic Oncology. 2024;22(1):68-77. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600180009
Cited By 1; Full text PubReader ePub PDF

Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients: Stefani Frost, Parisa Ziarati, Ryan Moen, Lynn Kysh, Robert Johnson, Shane Pearce, Siamak Daneshmand, Kimberly D. Siegmund, Victoria K. Cortessis; Journal of Urologic Oncology. 2024;22(1):78-94. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600020001
Cited By 1; Full text PubReader ePub PDF Supplementary Material

Declaration of Conflict of Interest for Editorial Board Members’ Articles: Editorial Office, Korean Urological Oncology Society; Journal of Urologic Oncology. 2024;22(1):95-96. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.2024.err01
Corrects: 2023;21(1):5
Corrects: 2023;21(1):14
Corrects: 2023;21(1):23
Corrects: 2023;21(1):53
Corrects: 2023;21(1):59
Corrects: 2023;21(1):79
Corrects: 2023;21(2):140; Full text PubReader ePub PDF

5,669	Complex Epidemiology of Prostate Cancer in Asian Countries
3,880	Current Update on Prostate Cancer Immunotherapy
3,475	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
3,443	Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023
3,428	Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up

Cited By 10	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 10	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 3	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By 3	Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
Cited By 3	Global Renal Cell Carcinoma Research Trends Over 30 Years: A PRISMA-Compliant Bibliometric Analysis

Previous issues